“…A number of factors, including the character and intensity of external pain stimuli, age, gender, weight and genetic variation, may affect analgesic requirements. Among these, the contribution of variations in the CYP3A4 and OPRM1 genes has attracted considerable attention (10)(11)(12)(13)(14)(15)(16)(17)(18)(19)(20)(21)24). The CYP3A4*18B polymorphism was identified to be associated with significant variability in fentanyl consumption 48 h following radical gastrectomy in Chinese Han patients.…”